3条公司动态
●蓝怡科技和北方生物战略合作,推动在体外诊断领域的技术革新和市场拓展
●最早一批的国产内窥镜厂商,正在重塑行业格局
●精密诊断公司Oncocyte和Bio-Rad合作推出全球移植检测试剂盒
3条新产品
●国内首款,华大智造发布多...查看全文
医业观察星哥2023-04-16 19:05
有观点,有态度
这是医业观察的第1748-5期文章
来源:360Dx,IVD联盟
纽约——Oncocyte 周三表示,它已裁员约 20%,该公司管理层表示,这应该会在 2024 年延长其现金跑道。
“那些受到影响的人总是把病人放在第一位。我们感谢他们对临床社区的奉献和服务,”首席执行官 Joshua ...查看全文
氨基观察2022-12-20 11:53
随着资本泛滥时代结束,依赖股权融资的肿瘤精准医疗公司,或许才意识到自己手中的现金原来十分拮据。
如今,他们都面临同样一个局面:开源、节流。
不过,“开源”对于大部分企业来说,是一大挑战。毕竟,市场的不成熟、商业化挑战极大、过于“内卷”等诸多因素导致,企业依靠肿瘤精准医疗...查看全文
蹊之美股生物医药2021-08-12 21:30
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
CohBar (NASDAQ:CWBR)+25%Allied Healthcare Products (NASDAQ:AHPI)+18%Doximity (NYSE:DOCS)+33%Orphazyme (NASDAQ:ORPH) +16%Fulcrum Therapeutics (NASDAQ:FULC) +7%
Losers:
Biodesix...查看全文
YOLO道2021-01-03 12:13
$Oncocyte(OCX)$
医疗保健的未来将显得如此不同,以至于你可能会觉得自己走进了一个新的宇宙。从远程医疗到精准医疗再到基因治疗,全球医疗行业将发生前所未有的动荡。
尽管如此,实现这一目标的关键支柱之一是基因检测,这涉及绘制人类整个基因组图谱。该地图上的信息是无价的。它是通...查看全文
皮神超级欧2020-12-15 22:06
$Oncocyte(OCX)$
ONCOCYTE AND BURNING ROCK EXECUTE STRATEGIC AGREEMENT TO DISTRIBUTE DETERMARX IN CHINA今天的PR。我说怎么主公司$Lineage Cell(LCTX)$ 最近涨的还行。那么另一家分公司$AgeX Therapeutics(AGE)$ 是不是也有机会?查看全文
$OncoCyte Corporation When Issued(OCX)$ 8-K - Current report Filed: 2017-03-10 AccNo: 0001493152-17-002325 Size: 27 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers h...
$OncoCyte Corporation When Issued(OCX)$ 8-K - Current report Filed: 2017-03-06 AccNo: 0001140361-17-010657 Size: 89 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$OncoCyte Corporation When Issued(OCX)$ 8-K - Current report Filed: 2017-03-03 AccNo: 0001140361-17-010539 Size: 20 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers h...
$OncoCyte Corporation When Issued(OCX)$ 8-K - Current report Filed: 2017-02-27 AccNo: 0001140361-17-009380 Size: 140 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$OncoCyte Corporation When Issued(OCX)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-02-27 AccNo: 0001140361-17-009369 Size: 7 MB 网页链接
$OncoCyte Corporation When Issued(OCX)$ 8-K - Current report Filed: 2017-02-24 AccNo: 0001140361-17-009201 Size: 230 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 5.02: Departure of Directors or Certain Officers;...
$OncoCyte Corporation When Issued(OCX)$ UPLOAD [Cover] - SEC-generated letter Filed: 2016-10-11 AccNo: 0000000000-16-096528 Size: 34 KB 网页链接
$OncoCyte Corporation When Issued(OCX)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2016-11-16 AccNo: 0001140361-16-086882 Size: 421 KB 网页链接
$OncoCyte Corporation When Issued(OCX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-10 AccNo: 0001140361-16-085842 Size: 2 MB 网页链接
$OncoCyte Corporation When Issued(OCX)$ 8-K - Current report Filed: 2016-11-10 AccNo: 0001140361-16-085838 Size: 265 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接